Michael E Prevoznik sold $5.7M of Quest Diagnostics Incorporated (DGX)

Executed Nov 29 2024, disclosed Dec 2 2024, 3 days later.

Value, as filed

$5.7M

35,146 sh across 2 lots

Executed

Nov 29 2024

the trade date, as filed

Disclosed

Dec 2 2024

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Michael E Prevoznik SVP & General Counsel profile →

Michael E Prevoznik (SVP & General Counsel) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Quest Diagnostics Incorporated (DGX). The largest single filing was $5.5M of DGX (22,677 sh across 3 lots, as filed), executed Aug 28.

The name

DGX

Quest Diagnostics Incorporated DGX · Healthcare · 49 filings in 24 months ticker →

Healthcare · Quest Diagnostics Incorporated provides diagnostic testing and services in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael E Prevoznik in DGX

DGXSALE Quest Diagnostics Incorporated $5.5M
22,677 sh across 3 lots
Exec Aug 28
Filed Aug 31 · 4:37 PM ET DGXSALE Quest Diagnostics Incorporated $800K
3,878 sh × $206.21
Exec Mar 5
Filed Mar 6 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $109K
526 sh × $207.73
Exec Mar 3
Filed Mar 4 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $228K
1,111 sh × $204.83
Exec Feb 19
Filed Feb 20 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $5.3M
28,288 sh × $187.12
Exec Sep 23 2025
Filed Sep 25 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $789K
4,643 sh × $170.00
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $104K
592 sh × $175.79
Exec Mar 4 2025
Filed Mar 5 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $103K
604 sh × $170.99
Exec Feb 20 2025
Filed Feb 21 2025 · 5:30 PM ET